Disruptive Technology ChannelETF of the Week: ARK Genomic Revolution Multi-Sector Fund (ARKG)By Aaron NeuwirthJuly 2, 2020
Disruptive Technology ChannelCoronavirus Flareup Sparked a Great Week for Active Genomics ETFBy Tom LydonJune 29, 2020
Innovative ETFs ChannelBiotech ETFs Rally After Inovio Locks in DOD Coronavirus DealBy Max ChenJune 23, 2020
Innovative ETFs ChannelThis Genomics ETF is Performing Like a Freak of NatureBy Ben HernandezMay 27, 2020
Disruptive Technology ChannelPower of Precision Medicine Could be Fueled HereBy Tom LydonMay 22, 2020
Disruptive Technology ChannelGenomics ETF Setting Up Nicely for the Long-TermBy Tom LydonMay 18, 2020
Disruptive Technology ChannelGenomic Stocks Are in the First Inning of a Multi-Year MegatrendBy Special To ETF TrendsMay 16, 2020
Disruptive Technology ChannelWhy ETF Investors Should Consider Allocating to InnovationBy Max ChenMay 14, 2020
Disruptive Technology ChannelMaking the Case for Innovation: Rethinking Traditional Asset AllocationBy Max ChenMay 13, 2020
Disruptive Technology ChannelVirus Detection Is Just One Catalyst for This Hot Genomics ETFBy Tom LydonMay 5, 2020
Disruptive Technology ChannelETF of the Week: ARK Genomic Revolution Multi-Sector Fund (ARKG)By Aaron NeuwirthApril 30, 2020
Disruptive Technology ChannelThis Biotechnology ETF Could Be the Place to Be in a RecessionBy Tom LydonApril 27, 2020
Disruptive Technology ChannelThis Genomics ETF Is up to Its Old Tricks and That’s Great For InvestorsBy Tom LydonApril 20, 2020
